Molecular and developmental mechanisms of congenital heart valve disease.
about
Increased dietary intake of vitamin A promotes aortic valve calcification in vivoTransforming growth factor Beta2 is required for valve remodeling during heart developmentMuscleblind-like 1 is required for normal heart valve development in vivo.RNA-seq analysis to identify novel roles of scleraxis during embryonic mouse heart valve remodelingReciprocal interactions between mitral valve endothelial and interstitial cells reduce endothelial-to-mesenchymal transition and myofibroblastic activation.Atrioventricular valve development: new perspectives on an old theme.Histone Deacetylase 3 Coordinates Deacetylase-independent Epigenetic Silencing of Transforming Growth Factor-β1 (TGF-β1) to Orchestrate Second Heart Field DevelopmentIsolation of murine valve endothelial cellsThe heart-placenta axis in the first month of pregnancy: induction and prevention of cardiovascular birth defectsBMPER regulates cardiomyocyte size and vessel density in vivo.Tgfβ-Smad and MAPK signaling mediate scleraxis and proteoglycan expression in heart valves.Progenitor cells confer plasticity to cardiac valve endothelium.Effect of altered haemodynamics on the developing mitral valve in chick embryonic heart.Increased ischaemia-modified albumin is associated with inflammation in acute rheumatic fever.MiR-23b and miR-199a impair epithelial-to-mesenchymal transition during atrioventricular endocardial cushion formation.CD45 Expression in Mitral Valve Endothelial Cells After Myocardial Infarction.Postnatal and Adult Aortic Heart Valves Have Distinctive Transcriptional Profiles Associated With Valve Tissue Growth and Maintenance Respectively.
P2860
Q24630155-C5657B1C-2770-4977-8C3B-A81496E58CA2Q28505676-2A467FF6-41AF-440C-98E3-596C91BC4FB5Q30668792-E520CFA7-C8BB-40CA-A08A-CE161A3CAF95Q33831074-23DF10E5-2DB9-4565-BBB6-C9E2E9439F65Q35137484-D08615F5-31F2-4D7C-81B8-DC6B8631133AQ36074327-FCD53624-1FD2-435A-A326-AA0FDE99AC50Q36283869-FCEDC6D2-0467-4D4F-A816-EC8F54D66366Q36593590-655683B4-7ABF-4681-A0BE-C8C31B8B66E9Q36838251-BE5F637E-2B67-4A9E-B064-E07A0B280256Q37265279-A8133059-E844-407C-BB74-4D291EB7AC81Q37406574-B44A8244-80B9-4B61-8077-F444533E465EQ37905729-2BC2E52B-672B-4646-AC70-60F005ED0FE3Q38747621-92ABAC16-C0DC-462D-813B-7F1DA3470132Q40248356-8C6FD0CF-5B70-4D03-A58D-E639195CA532Q40711568-0D022B06-668A-47A1-A55E-904B68E00DAAQ43289241-BD1D7346-B944-448B-93B6-642565458CADQ53824116-EB011CC1-C935-4651-875E-989F2182E27C
P2860
Molecular and developmental mechanisms of congenital heart valve disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 April 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Molecular and developmental mechanisms of congenital heart valve disease.
@en
Molecular and developmental mechanisms of congenital heart valve disease.
@nl
type
label
Molecular and developmental mechanisms of congenital heart valve disease.
@en
Molecular and developmental mechanisms of congenital heart valve disease.
@nl
prefLabel
Molecular and developmental mechanisms of congenital heart valve disease.
@en
Molecular and developmental mechanisms of congenital heart valve disease.
@nl
P2860
P356
P1476
Molecular and developmental mechanisms of congenital heart valve disease.
@en
P2093
Joy Lincoln
Katherine E Yutzey
P2860
P304
P356
10.1002/BDRA.20799
P577
2011-04-28T00:00:00Z